Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kwan Y Lee

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The Joint Commission Journal on Quality Improvement|March 21, 2002
Using comparison charts to assess performance measurement dataKwan Y Lee, Christine McGreevey
Managed Care Interface|December 29, 2007
The Medicare Part D doughnut hole: effect on pharmacy utilizationShawn X Sun, Kwan Y Lee
Clinical Therapeutics|March 14, 2009
Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarctionShawn X Sun, Xiaolan Ye, Kwan Y Lee, et al.
Current Medical Research and Opinion|July 4, 2007
Withdrawal of COX-2 selective inhibitors rofecoxib and valdecoxib: impact on NSAID and gastroprotective drug prescribing and utilizationShawn X Sun, Kwan Y Lee, Carl T Bertram, et al.
Quality Management in Health Care|May 7, 2004
Application of variables control charts to risk-adjusted time-ordered healthcare dataMarilyn K Hart, James W Robertson, Robert F Hart, et al.
Quality Management in Health Care|February 21, 2003
Application of attribute control charts to risk-adjusted data for monitoring and improving health care performanceMarilyn K Hart, Kwan Y Lee, Robert F Hart, et al.
Journal of Women'S Health (2002)|June 10, 2008
Gender and age differences in medications dispensed from a national chain drugstoreMarietta Anthony, Kwan Y Lee, Carl T Bertram, et al.
Cancer|December 4, 2008
Promoter methylation of the Wnt/beta-catenin signaling antagonist Dkk-3 is associated with poor survival in gastric cancerJun Yu, Qian Tao, Yuen Y Cheng, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 27, 2007
The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomasStephen L Chan, Yan Cui, Andrew van Hasselt, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The Joint Commission Journal on Quality Improvement|March 21, 2002
Using comparison charts to assess performance measurement dataKwan Y Lee, Christine McGreevey
Managed Care Interface|December 29, 2007
The Medicare Part D doughnut hole: effect on pharmacy utilizationShawn X Sun, Kwan Y Lee
Clinical Therapeutics|March 14, 2009
Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarctionShawn X Sun, Xiaolan Ye, Kwan Y Lee, et al.
Current Medical Research and Opinion|July 4, 2007
Withdrawal of COX-2 selective inhibitors rofecoxib and valdecoxib: impact on NSAID and gastroprotective drug prescribing and utilizationShawn X Sun, Kwan Y Lee, Carl T Bertram, et al.
Quality Management in Health Care|May 7, 2004
Application of variables control charts to risk-adjusted time-ordered healthcare dataMarilyn K Hart, James W Robertson, Robert F Hart, et al.
Quality Management in Health Care|February 21, 2003
Application of attribute control charts to risk-adjusted data for monitoring and improving health care performanceMarilyn K Hart, Kwan Y Lee, Robert F Hart, et al.
Journal of Women'S Health (2002)|June 10, 2008
Gender and age differences in medications dispensed from a national chain drugstoreMarietta Anthony, Kwan Y Lee, Carl T Bertram, et al.
Cancer|December 4, 2008
Promoter methylation of the Wnt/beta-catenin signaling antagonist Dkk-3 is associated with poor survival in gastric cancerJun Yu, Qian Tao, Yuen Y Cheng, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 27, 2007
The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomasStephen L Chan, Yan Cui, Andrew van Hasselt, et al.
Pageof 1